Table 1.

Relative expression of genes in different T treatment groups (fold change) versus the intact group (p values in the low T-treated group are indicated; statistically significant differences (ANOVA, p < 0.05) from other groups are indicated by *). Additional genes examined without significant difference from intact group: Cyp11a1, Cyp17a1, Hsd3b2, Akr1c1, Akr1c2, Akr1c3, Srd5a1, Srd5a2, Slco1b3, Slco1a5, Slco2a1

Gene	Low T (p value)	Med T	High T	Castrate
Ar	1.7(0.009)	0.93	1.15	0.96
Slco2b1	1.1(0.998)	0.82	0.69	4.48*
Abp	1.87 (0.121)	1.00	1.72	0.59
Lrp2	1.8 (0.427)	1.02	0.98	1.50
Hsd3b1	2.03(0.042)	1.36	1.16	0.40
Hsd17b1	2.74(0.008)	1.91	2.06	1.22
Hsd17b3	3.67(0.029)	2.98	2.76	3.21
Hsd17b6	2.92(0.005)	1.19	0.52	0.16
Hsd17b9	2.25(0.041)	2.04	1.60	1.37
Srd5a3	1.68(0.083)	1.46	1.59	0.80
Hsd17b7	1.06(0.998)	0.98	1.23	0.33*
Hsd17b10	1.56(0.015)	0.98	1.27	0.97
Cyp19a1	1.60(0.037)	1.20	1.37	0.83
Sult1e1	3.32(0.112)	1.85	1.21	0.69
Hsd17b2	3.07(0.140)	2.14	2.13	1.98
Gusb	4.06(0.635)	3.50	1.98	2.72
Arsc1	1.72 (0.081)	1.30	1.21	1.20